• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与中国南方相比,北方 2 型糖尿病患者的大血管和微血管并发症更多:一项横断面研究。

Greater macrovascular and microvascular morbidity from type 2 diabetes in northern compared with southern China: A cross-sectional study.

机构信息

Department of Endocrinology and Metabolism, Xijing Hospital, Xi'an, Shaanxi, China.

Department of Cardiology, Peking University People's Hospital, Beijing, China.

出版信息

J Diabetes Investig. 2020 Sep;11(5):1285-1294. doi: 10.1111/jdi.13262. Epub 2020 May 4.

DOI:10.1111/jdi.13262
PMID:32227466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7477533/
Abstract

AIMS/INTRODUCTION: There are substantial differences in genes, diet, culture and environment between the northern and southern Chinese populations, which might influence treatment strategy and screening policy. We studied the differences in type 2 diabetes and diabetic complications between northern and southern China.

MATERIALS AND METHODS

We carried out a cross-sectional survey using data from the China Cardiometabolic Registries on blood pressure, blood lipids and blood glucose in 25,398 Chinese type 2 diabetes patients. Macrovascular, microvascular and other complications were collected by self-report or medical records, and then divided into the northern and southern groups by the boundary of the Yangtze River.

RESULTS

Northern patients were younger, and had heavier weight, greater body mass index and waist circumference, higher blood pressure, higher total cholesterol, higher low-density lipoprotein cholesterol, and higher hemoglobin A1C. The prevalence of cardiovascular, cerebrovascular and macrovascular complications were 1.76-fold, 1.24-fold and 1.47-fold more in northern than that in southern Chinese patients. In addition, the prevalence of diabetic nephropathy, retinopathy, neuropathy and microvascular complications in northern Chinese patients also increased. When stratified by age, the difference in both cardiovascular disease and ischemic stroke morbidity became significant, even in the 35-44 years age group.

CONCLUSIONS

More macrovascular and microvascular complications were found in northern compared with southern patients, and the largest difference also appeared in the younger age groups <55 years, which might be meaningful to a screening and treatment strategy according to geographic differences.

摘要

目的/引言:中国南北人群在基因、饮食、文化和环境方面存在很大差异,这可能会影响治疗策略和筛查政策。我们研究了中国南北人群 2 型糖尿病及其并发症的差异。

材料和方法

我们使用中国心血管代谢注册研究的血压、血脂和血糖数据,对 25398 例中国 2 型糖尿病患者进行了横断面调查。通过自我报告或病历收集大血管、微血管和其他并发症,并按长江边界将其分为南北两组。

结果

北方患者较年轻,体重、体重指数和腰围较大,血压、总胆固醇、低密度脂蛋白胆固醇和糖化血红蛋白较高。与南方患者相比,北方患者心血管、脑血管和大血管并发症的患病率分别高出 1.76 倍、1.24 倍和 1.47 倍。此外,北方患者糖尿病肾病、视网膜病变、神经病变和微血管并发症的患病率也有所增加。按年龄分层,心血管疾病和缺血性卒中发病率的差异变得显著,甚至在 35-44 岁年龄组也是如此。

结论

与南方患者相比,北方患者有更多的大血管和微血管并发症,而且在<55 岁的年轻人群中差异最大,这可能对根据地域差异制定筛查和治疗策略具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0c/7477533/c4584a69b9a4/JDI-11-1285-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0c/7477533/bdd5ce0340fe/JDI-11-1285-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0c/7477533/c4584a69b9a4/JDI-11-1285-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0c/7477533/bdd5ce0340fe/JDI-11-1285-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0c/7477533/c4584a69b9a4/JDI-11-1285-g002.jpg

相似文献

1
Greater macrovascular and microvascular morbidity from type 2 diabetes in northern compared with southern China: A cross-sectional study.与中国南方相比,北方 2 型糖尿病患者的大血管和微血管并发症更多:一项横断面研究。
J Diabetes Investig. 2020 Sep;11(5):1285-1294. doi: 10.1111/jdi.13262. Epub 2020 May 4.
2
Cardiovascular health metrics defined by Life's Essential 8 scores and subsequent macrovascular and microvascular complications in individuals with type 2 diabetes: A prospective cohort study.由 Life's essential 8 评分定义的心血管健康指标与 2 型糖尿病患者的大血管和微血管并发症的关系:一项前瞻性队列研究。
Diabetes Obes Metab. 2024 Jul;26(7):2673-2683. doi: 10.1111/dom.15583. Epub 2024 Apr 1.
3
BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.体重指数(BMI)及 2 型糖尿病发病后 BMI 的变化与微血管和大血管并发症风险的关系:EPIC-Potsdam 研究。
Diabetologia. 2021 Apr;64(4):814-825. doi: 10.1007/s00125-020-05362-7. Epub 2021 Jan 15.
4
Microvascular and macrovascular complications in type 2 diabetes Ghanaian residents in Ghana and Europe: The RODAM study.加纳和欧洲 2 型糖尿病加纳居民的微血管和大血管并发症:RODAM 研究。
J Diabetes Complications. 2019 Aug;33(8):572-578. doi: 10.1016/j.jdiacomp.2019.04.016. Epub 2019 May 10.
5
N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes.脑钠肽原N端片段与2型糖尿病微血管并发症相关。
Vasc Health Risk Manag. 2014 Oct 3;10:585-9. doi: 10.2147/VHRM.S67753. eCollection 2014.
6
A multi-centre investigation of macrovascular and non-ocular microvascular complications in children and adolescents with diabetes mellitus in southern Ghana.加纳南部儿童和青少年糖尿病患者大血管和非眼部微血管并发症的多中心研究。
Ghana Med J. 2023 Jun;57(2):87-96. doi: 10.4314/gmj.v57i2.2.
7
Cardiovascular Risk Factor Status in Hospitalized Patients With Type 2 Diabetes in China.中国住院 2 型糖尿病患者的心血管危险因素状况。
Front Endocrinol (Lausanne). 2021 Jul 22;12:664183. doi: 10.3389/fendo.2021.664183. eCollection 2021.
8
Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabetic patients.血清 C 肽水平与韩国 2 型糖尿病患者慢性微血管并发症的关系。
Acta Diabetol. 2012 Feb;49(1):9-15. doi: 10.1007/s00592-010-0249-6. Epub 2011 Jan 7.
9
A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism.一项针对伴有和不伴有甲状腺功能减退症的2型糖尿病患者微血管并发症的横断面队列研究。
Cardiovasc J Afr. 2020;31(1):5-8. doi: 10.5830/CVJA-2019-036. Epub 2019 Aug 2.
10
Vascular complications in relation to ethnicity in non-insulin-dependent diabetes mellitus.非胰岛素依赖型糖尿病中与种族相关的血管并发症
Eur J Clin Invest. 1997 Mar;27(3):182-8. doi: 10.1046/j.1365-2362.1997.840637.x.

引用本文的文献

1
Prevalence and co-prevalence of comorbidities among Chinese adult patients with type 2 diabetes mellitus: a cross-sectional, multicenter, retrospective, observational study based on 3B study database.基于 3B 研究数据库的横断面、多中心、回顾性、观察性研究:中国成年 2 型糖尿病患者合并症的患病率和共患病率。
Front Endocrinol (Lausanne). 2024 Jun 11;15:1362433. doi: 10.3389/fendo.2024.1362433. eCollection 2024.
2
Right ventricular volume and function by three-dimensional echocardiography: results of the echocardiographic measurements in normal Chinese adults (EMINCA) II.三维超声心动图评估右心室容积与功能:中国正常成年人超声心动图测量结果(EMINCA)II
MedComm (2020). 2024 Apr 21;5(5):e550. doi: 10.1002/mco2.550. eCollection 2024 May.
3

本文引用的文献

1
Epidemiology and determinants of type 2 diabetes in south Asia.南亚 2 型糖尿病的流行病学和决定因素。
Lancet Diabetes Endocrinol. 2018 Dec;6(12):966-978. doi: 10.1016/S2213-8587(18)30204-3. Epub 2018 Oct 1.
2
Regional Differences in the Prevalence of Coronary Heart Disease and Stroke in Patients With Type 2 Diabetes in China.中国 2 型糖尿病患者冠心病和中风的患病率存在地域差异。
J Clin Endocrinol Metab. 2018 Sep 1;103(9):3319-3330. doi: 10.1210/jc.2018-00422.
3
Regional differences in the prevalence of diabetic retinopathy: a multi center study in Brazil.
Total phenolic contents, cytotoxic, free radicals, porcine pancreatic α-amylase, and lipase suppressant activities of plant from Palestine.巴勒斯坦植物的总酚含量、细胞毒性、自由基、猪胰α淀粉酶及脂肪酶抑制活性
Front Pharmacol. 2024 Mar 7;15:1351743. doi: 10.3389/fphar.2024.1351743. eCollection 2024.
4
Ethnic differences in the association between age at diagnosis of diabetes and the risk of cardiovascular complications: a population-based cohort study.种族差异与糖尿病诊断年龄和心血管并发症风险的关联:基于人群的队列研究。
Cardiovasc Diabetol. 2023 Sep 4;22(1):241. doi: 10.1186/s12933-023-01951-z.
5
Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations.中国和印度人群 2 型糖尿病的病理生理学、表型和管理。
Nat Rev Endocrinol. 2022 Jul;18(7):413-432. doi: 10.1038/s41574-022-00669-4. Epub 2022 May 4.
6
Salivary microbiota analysis of patients with membranous nephropathy.膜性肾病患者唾液微生物组分析。
Mol Med Rep. 2022 May;25(5). doi: 10.3892/mmr.2022.12706. Epub 2022 Apr 1.
糖尿病视网膜病变患病率的地区差异:巴西的一项多中心研究
Diabetol Metab Syndr. 2018 Mar 14;10:17. doi: 10.1186/s13098-018-0319-4. eCollection 2018.
4
Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity.体重指数与心血管疾病终生风险及发病年龄压缩的关联。
JAMA Cardiol. 2018 Apr 1;3(4):280-287. doi: 10.1001/jamacardio.2018.0022.
5
[Geographical variation and related factors in prediabetes prevalence in Chinese adults in 2013].[2013年中国成年人群糖尿病前期患病率的地理差异及相关因素]
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Feb 6;52(2):158-164. doi: 10.3760/cma.j.issn.0253-9624.2018.02.008.
6
The effects of economic development and built environment on diabetes in CHINA.中国经济发展和建筑环境对糖尿病的影响。
Popul Health Metr. 2017 Sep 29;15(1):35. doi: 10.1186/s12963-017-0152-2.
7
The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.脉搏波速度与 2 型糖尿病患者周围神经病变的关系。
J Diabetes Complications. 2017 Nov;31(11):1624-1629. doi: 10.1016/j.jdiacomp.2017.07.010. Epub 2017 Jul 27.
8
Assessing genome-wide copy number variation in the Han Chinese population.评估汉族人群全基因组拷贝数变异。
J Med Genet. 2017 Oct;54(10):685-692. doi: 10.1136/jmedgenet-2017-104613. Epub 2017 Jul 13.
9
Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013.2013年中国糖尿病及糖尿病前期的患病率与民族分布特征
JAMA. 2017 Jun 27;317(24):2515-2523. doi: 10.1001/jama.2017.7596.
10
Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe.超重、肥胖与心血管代谢多重疾病风险:对来自美国和欧洲16项队列研究的120813名成年人个体水平数据的汇总分析。
Lancet Public Health. 2017 May 19;2(6):e277-e285. doi: 10.1016/S2468-2667(17)30074-9. eCollection 2017 Jun.